Martin Babler
President, Chief Executive Officer and Chairman of the Board at Alumis
San Francisco, California, United States
Find your path to Martin
27 people in our graph share verified history with Martin — schools, employers, funds. One of them is your warm intro.
Carlos A. SchulerunlockedMartin: together at Talima Therapeutics (2010–2011)
Martin: together at ZS Pharma, Inc.
Martin: together at MMA
×4Martin: together at Sardona Therapeutics
President, Chief Executive Officer and Chairman of the Board at Alumis
Intro paths
→
In turn, Martin can intro founders to Alumis's investors below.
Alumis's investors · 8
Foresite CapitalWest Hollywood · since 2024Nextech InvestZurich · $648K – $3.2M checksOrbiMedNew York · $1M – $75M checksSamsara BioCapitalPalo AltoSR One Capital ManagementRedwood CityvenBio Global StrategicSan Francisco · since 2024venBio PartnersSan Francisco · since 2024Westlake Village BioPartnersLos Angeles · $100K – $5M checks
Experience
- AlumisChairman, President and CEOcurrent2021 — presentSan Francisco Bay Area
- Prelude TherapeuticsBoard Membercurrent2021 — presentWilmington, Delaware, United States
- Paradigm Ranch Management LLCCo-Ownercurrent2008 — presentSonoma County, California, United States
- 89bioBoard Member2024 — 2025
- Sardona TherapeuticsChairman of the Board2021 — 2025San Francisco Bay Area
- Omega Alpha SPACBoard Member2021 — 2024Boston, Massachusetts, United States
- Neoleukin TherapeuticsBoard Member2020 — 2023
- Principia BiopharmaPresident and CEO2011 — 2020
- ZS Pharma, Inc.Board Member2015
- Talima TherapeuticsPresident and CEO2007 — 2011
- MMABoardmember2005 — 2007
- GenentechVP Sales and Marketing Immunology2003 — 2006
- Genentechvarious1998 — 2002
- Eli Lilly and Companyvarious1992 — 1998
Skills & more
Drug DiscoveryPharmaceutical IndustryClinical DevelopmentHealthcareBiotechnologyOncologyPharmaceutical SalesManaged CareCardiologyImmunologyLifesciencesBiopharmaceuticals
+10 more
Infectious DiseasesCommercializationMedical DevicesStart-upsStrategic PlanningNeurologyDrug DevelopmentProduct LaunchCross-functional Team LeadershipMolecular BiologyFrom Martin's professional profile.
Frequently asked questions
- Who is Martin Babler?
- President, Chief Executive Officer and Chairman of the Board at Alumis
- Where does Martin Babler work?
- Martin Babler is President, Chief Executive Officer and Chairman of the Board at Alumis.
Founder mafias
Principia Biopharma mafia6
Also came through, then founded or led a company.
Peter ThompsonDirectorFounded Cleave Biosciences +4Peter Thompson, M.D.Chairman of the BoardFounded Cleave Biosciences +4Mike DybbsDirectorFounded Kalaris Therapeutics, Inc.Richard A. MillerFounder, President, CEO and DirectorFounded CorvuspharmaSrinivas AkkarajuDirectorFounded Kalaris Therapeutics, Inc.
Shared employers
Also worked at Prelude Therapeutics1
Also worked at Neoleukin Therapeutics5
Also worked at Principia Biopharma6
Chris ChaiOperating Partner - Portfolio Capital Raising at SR One Capital ManagementMike DybbsPartner at Samsara BioCapitalPeter ThompsonGeneral Partner at OrbiMedPeter Thompson, M.D.Investor at OrbiMedRichard A. MillerPresident & CEO, Co-Founder at CorvuspharmaClaire LangrishSVP, Head of Immunology and Translational Science at Alumis






















